Novonesis to Invest €600 Million in India The Story: Novonesis will invest €600 million to expand its Patalganga site and build an advanced enzyme production facility, expected to be operational by 20...
Dr. Reddy’s Gets Abatacept Biosimilar Approval The Story: Dr. Reddy’s has received CDSCO approval for its abatacept biosimilar in India for rheumatoid arthritis and psoriatic arthritis. The Take: The ...
Mankind Pharma Inks Deal for Two Insulin Analogues The Story: Mankind Pharma has entered an exclusive agreement with Chongqing Chenan to commercialize Insulin Degludec and Insulin Degludec + Aspart in...
Elephas Biosciences, Neuberg Partner on Immuno-therapy Testing The Story: Elephas Biosciences has partnered with Neuberg Diagnostics to bring its elive live-tissue platform to India, with a clinical t...
Eisai Launches Leqembi in India for Early Alzheimer’s Disease The Story: Eisai has launched Leqembi (lecanemab) in India after CDSCO approval, introducing the country’s first disease-modifying t...
